The shift to a VBC model represents more than an evolution in healthcare delivery – it demands a fundamental redesign of our healthcare system and the economic models to support it. The post Unlocking Success in Value-Based Care: Why Focusing on Specialized Populations is Key appeared first on MedCity News.
Rural health organizations cannot afford to get dazzled by AI demo candy. There is no such thing as “FixHealthcareGPT,” and investing in the wrong technology for the future isn’t going to do anything to improve patient outcomes today. The post Rural Healthcare Transformation Has to Focus on the Real World, Not Techno-Fantasies appeared first on…
Breach exposed sensitive information and left the personal data of 600,000 individuals vulnerable
A data safety monitoring board recommended pausing the Phase 2b test of Pliant’s bexotegrast, an experimental treatment for idiopathic pulmonary fibrosis. The move follows a prespecified data review, the company said. The post Pliant Therapeutics Presses Pause on Clinical Trial for Lung Disorder Drug appeared first on MedCity News.
Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and…
The Justice Department’s years-long court battle to force UnitedHealth Group to return billions of dollars in alleged Medicare Advantage overpayments hit a major setback Monday when a special master ruled the government had failed to prove its case. In finding for UnitedHealth, Special Master Suzanne Segal found that the DOJ had not presented evidence to…
Veradermics’s drug, a pill version of the topical hair loss product minoxidil, was developed with technology intended to avoid the cardiovascular risks associated with oral dosing of this compound. The first of three pivotal clinical trials is expected to yield preliminary data in the first half of 2026. The post Baldness Biotech Veradermics Prices $256M…
Here’s a roadmap that brings together a wide range of existing and new initiatives under four key goals that enable community-based organizations to take stock of their existing capabilities and coordinate across them effectively. The post Protecting Members’ Medicaid Coverage Must Start Now appeared first on MedCity News.
By KIM BELLARD I hadn’t expected to write about a biology-related topic anytime soon after doing so last week, but, gosh darn it, then I saw a press release from Cornell about biohybrid robots – powered by mushrooms (aka fungi)! They had me at “biohybrid.” The release talks about a new paper — Sensorimotor…
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…